FDA Inspection 1327214 — Community Blood Center
The FDA completed an inspection of Community Blood Center on Jul 16, 2026 in Dayton, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 16, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Dayton, OH (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12343 | 21 CFR 1271.190(a) | State of repair |
| 12473 | 21 CFR 1271.350(b)(2) | Deviations not reported to FDA |